JUN 23, 2020 10:00 AM PDT

Mesenchymal stromal or stem cell (MSC) workflow for efficient clinical translation: from automated GMP-compliant cell manufacturing to standardized phenotyping

Sponsored by: Miltenyi Biotec
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Project Manager R&D, Miltenyi Biotec
    Biography
      Kathrin Godthardt joined Miltenyi Biotec's R&D department in 2001. She received her Bachelor's Degree from University of Mainz and finished her thesis on characterization of endothelia progenitor cells at Miltenyi Biotec. She has a long-term experience on separation technologies, development of cell culture media and adaptation of separation and cultivation processes into clinical-scale closed systems for mesenchymal stem cells. Currently she is a Team Coordinator and Project Manager of the R&D Stem cell and Regenerative Medicine Group.

    Abstract

    DATE:  June 23, 2020

    TIME:  10:00am PT

     

    Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, such as COVID-19 disease. Several clinical trials have been started, and preliminary data hold great promise for clinical use and cell therapy for this severe disease. To facilitate efficient clinical translation, we developed an automated GMP-compliant cell manufacturing procedure using the integrated cell processing platform CliniMACS Prodigy®, which increases the level of process standardization and product safety. In this new adherent cell culture (ACC) system, sample cells are processed in a closed system, including automated density gradient centrifugation in case of human bone marrow sample, feeding, replating, expanding, and harvesting procedures. Clinical applications of MSCs for spine and joint pain needs only small amount stem cells injected locally. However, for systemic illness such as COVID-19, millions of cells are needed for IV inject. Our xeno-free MSC-Brew GMP Medium, following the recommendations of USP <1043> on ancillary materials, enables efficient isolation and expansion of MSCs from different tissue sources including human bone marrow, adipose tissue, and umbilical cord. Together with the ACC system,  over 200 million MSCs can be generated from single donor in just 14 days. Cultured MSCs need to go through strict quality control before any clinical applications. Our new MSC phenotyping kit, including 3 positive and 5 negative MSC markers based on ISCT standard, facilitates standardized and reliable phenotyping of cultured human MSCs from different tissue sources. The high-purity recombinant engineered antibodies (REAfinity™) in the kit ensures high lot-to-lot consistency and reproducible results in flow cytometry.  

     

    Learning objectives:

    • Discuss GMP grade serum-free and xeno-free Medium for efficient MSCs expansion from different tissue resources
    • Discuss Automated and closed Adherent Cell Culture (ACC) System for GMP scale MSC production
    • Discuss Standardized and reliable phenotyping of cultured MSCs

     

     

    Webinars will be available for unlimited on-demand viewing after live event.

     

    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


    Show Resources
    You May Also Like
    OCT 08, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    SEP 02, 2020 7:00 AM PDT
    C.E. CREDITS
    SEP 02, 2020 7:00 AM PDT
    DATE: September 2, 2020 TIME: 03:00pm PDT, 6:00pm EDT Spatial omics is an expanding collection of methods to examine biological molecules in their geographical context. By retaining the prec...
    Loading Comments...
    Show Resources
    Attendees
    • See more